These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 16938447)

  • 21. The impact of affective states on the perception of dyspnea in patients with chronic obstructive pulmonary disease.
    von Leupoldt A; Taube K; Henkhus M; Dahme B; Magnussen H
    Biol Psychol; 2010 Apr; 84(1):129-34. PubMed ID: 21768011
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Depressive symptoms and chronic obstructive pulmonary disease: effect on mortality, hospital readmission, symptom burden, functional status, and quality of life.
    Ng TP; Niti M; Tan WC; Cao Z; Ong KC; Eng P
    Arch Intern Med; 2007 Jan; 167(1):60-7. PubMed ID: 17210879
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Quality of life in COPD].
    Atasever A; Erdinç E
    Tuberk Toraks; 2003; 51(4):446-55. PubMed ID: 15143396
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Self-care approaches to managing chronic obstructive pulmonary disease: a provincial survey.
    Cicutto LC; Brooks D
    Respir Med; 2006 Sep; 100(9):1540-6. PubMed ID: 16483758
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of fluticasone propionate/salmeterol (250/50 microg) or salmeterol (50 microg) on COPD exacerbations.
    Ferguson GT; Anzueto A; Fei R; Emmett A; Knobil K; Kalberg C
    Respir Med; 2008 Aug; 102(8):1099-108. PubMed ID: 18614347
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of dyspnea and clinical variables on the quality of life and functional capacity in patients with chronic obstructive pulmonary disease and congestive heart failure.
    Karapolat H; Eyigor S; Atasever A; Zoghi M; Nalbantgil S; Durmaz B
    Chin Med J (Engl); 2008 Apr; 121(7):592-6. PubMed ID: 18466677
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Frequent chronic obstructive pulmonary disease exacerbators: how much real, how much fictitious?
    Soler-Cataluña JJ; Rodriguez-Roisin R
    COPD; 2010 Aug; 7(4):276-84. PubMed ID: 20673037
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Effect of dynamic hyperinflation on exertional dyspnea, exercise performance and quality of life in COPD].
    Ozgur ES; Atis S; Kanik A
    Tuberk Toraks; 2008; 56(3):296-303. PubMed ID: 18932031
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Living with chronic obstructive pulmonary disease: insiders' perspectives.
    Fraser DD; Kee CC; Minick P
    J Adv Nurs; 2006 Sep; 55(5):550-8. PubMed ID: 16907786
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Quality of life and social-economic characteristics of greek male patients on long-term oxygen therapy.
    Tsara V; Serasli E; Katsarou Z; Tsorova A; Christaki P
    Respir Care; 2008 Aug; 53(8):1048-53. PubMed ID: 18655743
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Variability of respiratory symptoms in severe COPD.
    Espinosa de los Monteros MJ; Peña C; Soto Hurtado EJ; Jareño J; Miravitlles M
    Arch Bronconeumol; 2012 Jan; 48(1):3-7. PubMed ID: 21944843
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Living with chronic obstructive pulmonary disease: developing conscious body management in a shrinking life-world.
    Gullick J; Stainton MC
    J Adv Nurs; 2008 Dec; 64(6):605-14. PubMed ID: 19120575
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [The importance of the at risk COPD patients (Stage 0) and clinical differences].
    Kömüs N; Tertemiz KC; Sevinç C
    Tuberk Toraks; 2008; 56(4):382-9. PubMed ID: 19123073
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Implications of chronic obstructive pulmonary disease (COPD) on patients' health status: a western view.
    Punekar YS; Rodriguez-Roisin R; Sculpher M; Jones P; Spencer M
    Respir Med; 2007 Mar; 101(3):661-9. PubMed ID: 17197164
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Symptom distress and quality of life in patients with advanced chronic obstructive pulmonary disease.
    Blinderman CD; Homel P; Billings JA; Tennstedt S; Portenoy RK
    J Pain Symptom Manage; 2009 Jul; 38(1):115-23. PubMed ID: 19232893
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Development of an activity of daily living scale for patients with COPD: the Activity of Daily Living Dyspnoea scale.
    Yoza Y; Ariyoshi K; Honda S; Taniguchi H; Senjyu H
    Respirology; 2009 Apr; 14(3):429-35. PubMed ID: 19207122
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Counting, analysing and reporting exacerbations of COPD in randomised controlled trials.
    Aaron SD; Fergusson D; Marks GB; Suissa S; Vandemheen KL; Doucette S; Maltais F; Bourbeau JF; Goldstein RS; Balter M; O'Donnell D; Fitzgerald M;
    Thorax; 2008 Feb; 63(2):122-8. PubMed ID: 17702790
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Severe chronic obstructive pulmonary disease in a family's everyday life in Finland: perceptions of people with chronic obstructive pulmonary disease and their spouses.
    Kanervisto M; Kaistila T; Paavilainen E
    Nurs Health Sci; 2007 Mar; 9(1):40-7. PubMed ID: 17300544
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Evaluation of acute bronchodilator reversibility in patients with symptoms of GOLD stage I COPD.
    O'Donnell DE; Laveneziana P; Ora J; Webb KA; Lam YM; Ofir D
    Thorax; 2009 Mar; 64(3):216-23. PubMed ID: 19052054
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinical and economic analysis of antimicrobial therapy of chronic obstructive pulmonary disease exacerbations.
    Simoens S; Decramer M; De Coster S; Celis G; Laekeman G
    Int J Clin Pract; 2007 Feb; 61(2):200-6. PubMed ID: 17263707
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.